ONMD:NASDAQOneMedNet Corp Analysis
Data as of 2026-07-20 - not real-time
$0.68
Latest Price
9/10Risk
Risk Level: High
Executive Summary
OneMedNet trades at $0.68, which sits below its 20‑day SMA of $0.68, its 50‑day SMA of $0.75, and its 200‑day SMA of $1.13, underscoring a clear bearish price bias. The RSI of 46.9 signals a neutral momentum zone, while the MACD line has just crossed above the signal line, offering a faint bullish hint that is outweighed by a decreasing volume trend and a staggering 30‑day volatility of 109% and an 84% historic drawdown.
Fundamentally, the company is in distress: revenue shrank 30%, gross margin is –50%, operating margin –26.6%, and EBITDA is –$9.9 M. Cash of $0.23 M is dwarfed by $0.84 M of debt, book value per share is –$0.08, and the price‑to‑book ratio sits at –8.8. With a price‑to‑sales of 29.4, no earnings, and zero dividend, the equity appears severely over‑priced relative to its deteriorating financial health.
Fundamentally, the company is in distress: revenue shrank 30%, gross margin is –50%, operating margin –26.6%, and EBITDA is –$9.9 M. Cash of $0.23 M is dwarfed by $0.84 M of debt, book value per share is –$0.08, and the price‑to‑book ratio sits at –8.8. With a price‑to‑sales of 29.4, no earnings, and zero dividend, the equity appears severely over‑priced relative to its deteriorating financial health.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below all major moving averages
- Decreasing volume and extreme 30‑day volatility
- Negative earnings and cash flow
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Continued revenue decline and widening losses
- High debt relative to cash
- Unfavorable price‑to‑sales multiple
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside if the company can execute a turnaround in its imaging platform
- Low beta (0.6) suggests limited market‑wide exposure
- Current market sentiment (Extreme Greed) could drive short‑term price spikes
Key Metrics & Analysis
Financial Health
Revenue Growth-29.90%
Profit Margin-254.32%
ROA-385.73%
P/B Ratio-8.8
Op. Cash Flow$-7191000
Free Cash Flow$-9647625
Industry P/E29.0
Technical Analysis
TrendBearish
RSI46.9
Support$0.54
Resistance$0.77
MA 20$0.68
MA 50$0.75
MA 200$1.13
MACDBullish
VolumeDecreasing
Fear & Greed Index88.68
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta0.60
Volatility109.47%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.